Singapore, Singapore
Pharmaceutical Sales Professional with 7+ years of experience managing hospital and specialist portfolios within multinational pharmaceutical environments in Singapore. Experienced across anti-infectives, immunology, biologics, pain management, and vaccines, with strong exposure to institutional account development and specialist engagement. Background includes biologics portfolio expansion and structured scientific detailing within competitive hospital settings. Major Highlights • 110–150% consistent sales target achievement • Expanded specialist channels (+25% new accounts) • Secured hospital formulary adoption within institutional settings • Delivered sustained territory revenue growth • Supported product launch preparation and cross-functional coordination Following a planned career sabbatical focused on family leadership, I return with strengthened resilience, adaptability, and structured execution discipline. Open to Specialty, Biologics, Hospital Account, or Product Specialist roles across multinational pharmaceutical companies, local distributors, and growing specialty-focused organizations in Singapore.
• Structured execution • Adaptability • Clear communicatio
Dedicated period focused on family leadership responsibilities while maintaining professional engagement and long-term career alignment. • Strengthened stakeholder coordination, planning, and execution discipline • Organized school and community initiatives requiring structured leadership and communication • Maintained professional networks and ongoing industry awareness
Led hospital and specialist portfolios including biologics, vaccines,pain management and anti-infectives within institutional settings. • Achieved 150%, 120%, 109% performance across key portfolios • Supported vaccine launch preparation within specialist channels • Strengthened institutional positioning through clinical engagement • Built KOL partnerships supporting specialty portfolio adoption • Delivered 15–20% territory growth
Managed anti-infectives and immunology portfolios, including biologics within hospital environments. • Expanded biologics specialist accounts (+25% growth) • Achieved above-target performance across portfolios • Secured hospital formulary adoption • Supported infectious disease product launch initiatives